Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Poortmans

Showing results (141-150 of 258) with videos related to

Pageof 26
Sort By:
Breast (Edinburgh, Scotland)|August 5, 2025
Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi studyOrit Kaidar-Person, André Pfob, Vincenzo Valentini, et al.
Neuro-Oncology|October 11, 2014
Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer NetworkDamien C Weber, Yucai Wang, Robert Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2006
Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network studyVirginie Monnard, Alex Sun, Ron Epelbaum, et al.
Breast Cancer Research and Treatment|July 9, 2024
A BRILLIANT-BRCA study: residual breast tissue after mastectomy and reconstructionOrit Kaidar-Person, Renata Faermann, Dor Polikar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2013
Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineationFemke van der Leij, Paula H M Elkhuizen, Tomas M Janssen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 20, 2013
Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trialsMukesh B Mukesh, Emma Harris, Sandra Collette, et al.
Breast (Edinburgh, Scotland)|August 20, 2025
Corrigendum to "Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study" [The Breast, Volume 83 (2025) 104537]Orit Kaidar-Person, André Pfob, Vincenzo Valentini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2004
The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trialPhilip Poortmans, Harry Bartelink, Jean-Claude Horiot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 24, 2021
Tricks and tips for target volume definition and delineation in breast cancer: Lessons learned from ESTRO breast coursesOrit Kaidar-Person, Birgitte V Offersen, Liesbeth Boersma, et al.
The Lancet. Oncology|June 27, 2016
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based studyMarissa C van Maaren, Linda de Munck, Geertruida H de Bock, et al.
Pageof 26

Showing results (141-150 of 258) with videos related to

Sort By:
Pageof 26
Breast (Edinburgh, Scotland)|August 5, 2025
Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi studyOrit Kaidar-Person, André Pfob, Vincenzo Valentini, et al.
Neuro-Oncology|October 11, 2014
Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer NetworkDamien C Weber, Yucai Wang, Robert Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2006
Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network studyVirginie Monnard, Alex Sun, Ron Epelbaum, et al.
Breast Cancer Research and Treatment|July 9, 2024
A BRILLIANT-BRCA study: residual breast tissue after mastectomy and reconstructionOrit Kaidar-Person, Renata Faermann, Dor Polikar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2013
Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineationFemke van der Leij, Paula H M Elkhuizen, Tomas M Janssen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 20, 2013
Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trialsMukesh B Mukesh, Emma Harris, Sandra Collette, et al.
Breast (Edinburgh, Scotland)|August 20, 2025
Corrigendum to "Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study" [The Breast, Volume 83 (2025) 104537]Orit Kaidar-Person, André Pfob, Vincenzo Valentini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2004
The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trialPhilip Poortmans, Harry Bartelink, Jean-Claude Horiot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 24, 2021
Tricks and tips for target volume definition and delineation in breast cancer: Lessons learned from ESTRO breast coursesOrit Kaidar-Person, Birgitte V Offersen, Liesbeth Boersma, et al.
The Lancet. Oncology|June 27, 2016
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based studyMarissa C van Maaren, Linda de Munck, Geertruida H de Bock, et al.
Pageof 26